Drug Updates

Drug updates provide the latest information and relevant warnings and notifications.

Update on Drugs & Devices: September-October 2023

Update on Cantharidin topical solution 0.7% (Ycanth™), Ritlecitinib capsules (Litfulo™), Clascoterone cream 1% (Winlevi®), and Isotretinoin capsules micronized formulation (Absorica LD®).

Update on Drugs and Drug News: May-June 2015

Update on Varicose vein n-butyl-2-cyanoacrylate adhesive polymer (VenaSeal™ Closure System), Dermal filler + calcium hydroxylapatite (CaHA) + integral 0.3% lidocaine (Radiesse®), Dalbavancin for IV injection (Xydalba™), Pembrolizumab for IV infusion (Keytruda®)

Update on Drugs and Drug News – March 2007

Update on Diclofenac Sodium 3% Gel Solaraze®, Retapamulin Ointment 1% Altabax™, Calcium Hydroxylapatite Microspheres in Water-based Gel Radiesse®, Rose Bengal Disodium 10% PV-10, and Taxane Potentiator STA-4783.

Update on Drugs and Drug News: December, 1996

Update on: Amphotericin B Lipid Complex Injection Abelcet®Butenafine HCl Cream 1% Mentax® Itraconazole Sporanox®Acitretin Soriatane® Penciclovir cream 1% Denavir®Valacyclovir Valtrex®Laser device Sharplan Silktouch laser®Permethrin lotion Nix®Ivermectin Mectizan® (6 mg tablet)

Update on Drugs and Drug News – May 2008

Update on Triphendiol (formerly NV-196), Cyclic pentapeptide vascular-targeting agent ADH-1, Certolizumab pegol Cimzia® and drug news from around the world.

Update on Drugs and Drug News: July – August 2009

Update on Benzyl Alcohol Lotion 5% Sciele Pharma, Red Light Technology Device + Methyl Aminolevulinate Cream Aktilite® CL 128 + Metvix®, and news Nexavar®.

Update on Drugs and Drug News: July-August 2014

Update on drugs Metronidazole 1.3% vaginal gel (Actavis plc), Ecallantide for SC injection (Kalbitor®), Dalbavancin for IV injection (Dalvance™), Taliglucerase alfa for IV injection (Elelyso™), and Efinaconazole 10% topical solution (Jublia®)

Update on Drugs and Drug News: May-June 2017

Update on Dupilumab for SC injection Dupixent®, Dupilumab for SC injection, Avelumab for IV injection Bavencio®, Hyaluronic acidbased injectable dermal filler Juvéderm®, Biosimilar to adalimumab for SC injection Amgevita™ Vollure™ XC, Adalimumab for SC injection Humira®, and Amgevita™.

Update on Drugs and Drugs News May 2005

Updates on: Fluocinonide 0.1% Cream Vanos™ Dalvancin Epinastine Hydrochloride Alesion® Dry Syrup 1% Griseofulvin Oral Suspension USP

Update on Drugs & Devices: November – December 2019

The latest drug & device update covers: Trifarotene 0.005% cream (Aklief®, Galderma), Afamelanotide implant (Scenesse®, Clinuvel Pharmaceuticals), Rituximab for IV use (Rituxan®, Genentech), Jynneos™ (Bavarian Nordic), Aczone® (Almirall) and Juvéderm Voluma® XC (Allergan)

2020 Index for Skin Therapy Letter – Dermatology Edition

This index covers all new skin treatments introduced in Skin Therapy Letter Dermatology Edition articles in 2020.

Update on Drugs and Drug News – March 2008

Update on Anti-psoriatic Agent Adalimumab (Humira®), Antihistamine (Claritin®), HIV drug Etravirine (Intelence™) and news about new antioxidant, coffeeberry (REVALÉSKIN™, Stiefel Laboratories)

Update on Drugs and Drug News: March 2002

Updates on: Naturally-Derived Alpha Interferon Efavirenz Sustiva®Estradiol/Levonorgestrel Alesse®HSPPC-96 Oncophage®Tenofovir Disoproxil Fumerate Viread® Desloratidine Clarinex® 5mg. Tablets

Update on Drugs and Drug News: April 2010

Update on drugs, approval dates, and comments. Collagenase clostridium histolyticum (XIAFLEX™), HPV quadrivalent recombinant vaccine (Gardasil®), Velaglucerase alfa (VPRIV™), Agalsidase alfa (REPLAGAL®), Adalimumab (Humira®) are covered.

Update on Drugs & Devices: September – October 2018

Updates on Binimetinib + Encorafenib (Mektovi® + Braftovi®), Crisaborole 2% ointment (Eucrisa™), Glycopyrronium tosylate 2.4% cloth (Qbrexza™), Secukinumab for SC injection (Consentyx®), Tecovirimat capsule (Tpoxx), Diacerein 1% ointment (CCP-020), Migalastat capsule (Galafold™), Mogamulizumabkpkc for IV use (Poteligeo®)

Update on Drugs & Devices: March – April 2020

This update covers Tazemetostat tablets/Tazverik™ (Epizyme, Inc.), Tazarotene lotion 0.045%/Arazlo™ (Ortho Dermatologics, Bausch Health) and Rituximab biosimilar for IV injection/ABP 798 (Amgen, Allergan).

Update on Drugs and Drug News: Number 3 2000

Updates on: 5-fluorouracil 5-FU Microsponge Interferon-Alpha Veldona Hydroxyurea Amprenavir Agenerase Diclofenac Sodium Solaraze

Update on Drugs & Devices: January – February 2019

Update on Dalbavancin hydrochloride for IV infusion (Xydalba™), Omadacycline for IV and oral use (Nuzyra™), Tildrakizumab-asmn for SC injection (Ilumya™), Adalimumab-adaz for SC injection (Hyrimoz™) and other new drugs and treatments.

Update on Drugs and Drug News: March 2001

Update on: Caspofungin Acetate Cancidas 5% Minoxidil Topical Solution Mequinol 2%, Tretinoin 0.1% Solagé Topical Solution Biologically Active Dressing Composite Cultured Skin (CCS) Xtrac Excimer Laser System

Update on Drugs & Devices: May – June 2023

Update on Targeted alkali thermolysis (TAT) technology (Brella™ 3-miniute SweatControl Patch™), Retifanlimab-dlwr for IV infusion (Zynyz™), Spesolimab IV for IV infusion (Spevigo®) and CRISPR-based therapy (NTLA-2002).

Update on Drugs and Drug News: September, 1998

Update on: Efavirenz Sustiva® Nevirapine Viramune®Famciclovir Famvir®Cetirizine Zyrtec® Rifapentine Priftin® Denileukin diftitox Ontak® Doxorubicin Caelyx® Graftskin Apligraf® Dangers of alternative medicine, Protease inhibitors during pregnancy

Update on Drugs and Drug News: November 2009

Updates on Ustekinumab Stelara® Centocor Ortho Biotech, Romidepsin ISTODAX® Gloucester Pharmaceuticals and news from US FDA.

Update on Drugs and Drug News – October 2006

Update on Ketoconazole 2% Gel Xolegel™, Famciclovir Tablets Famvir®, Ecamsule 2% + Avobenzone 2%/ Octocrylene 10% Cream Anthelios SX®, and news about lice treatment.

Update on Drugs and Drug News: September 2002

Updates on: Tazarotene Tazorac® 0.1% Cream Isotretinoin Accutane®Desloratidine Clarinex® 5mg Reditabs Imiquimod Aldara®

Update on Drugs and Drug News – June 2007

Update on Retapamulin Ointment 1% Altabax® GlaxoSmithKline, Quadrivalent Human Papillomavirus Recombinant Vaccine Gardasil® Merck, Quadrivalent Human Papillomavirus Recombinant Vaccine AERIUS®/ AZOMYR®/ NEOCLARITYN® Schering-Plough.

Update on Drugs and Drug News: January 2011

Update on drugs, approval dates, and comments. Calcipotriene/Calcipotriol0.005% foam (Sorilux™), Ceftaroline fosamil (Teflaro™) are covered as well as an update on Health Canada on the use of tacrolimus (Protopic®) for atopic dermatitis.

Update on Drugs and Drug News: September-October 2016

This update covers Pembrolizumab IV injection (Keytruda®), Hyaluronic acid gel filler (Juvéderm Volbella® XC), Biosimilar of infliximab (Flixabi®), Ceftaroline fosamil for IV infusion (Teflaro®), Dermal filler with calcium hydroxylapatite (CaHA) + integral 0.3% lidocaine (Radiesse® + Lidocaine), Ixekizumab SC injection (Talz®), Adapalene gel 0.1% (Differin® Gel), C1 esterase inhibitor(human) for IV infusion (Berinert®)

Update on Drugs and Drug News: July-August 2010

Update on drugs, approval dates, and comments. Belimumab (Benlysta®), Adapalene 0.1% gel, Antiseborrheic compound (K301/Kaprolac®) are covered.

Update on Drugs and Drug News: January-February 2016

January and February 2016: Update on drugs, approval dates, and comments. Autologous cell suspension (ReCell® ReGenerCell® ReNovaCell®), Calcipotriene 0.005% + betamethasone dipropionate 0.064% foam (Enstilar®), Ipilimumab (Yervoy®), Talimogene laherparepvec (T-Vec) oncolytic virus therapy (Imlygic™), Cobimetinib + vemurafenib (Cotellic™ + Zelboraf®), Dabrafenib + trametinib (Tafinlar® + Mekinist®), Nivolumab injection (Opdivo®) are covered.

Update on Drugs and Drug News: February 2011

Update on drugs, approval dates, and comments. Human papillomavirus quadrivalent (Types 6, 11, 16, and 18) recombinant vaccine (Gardasil®), Daptomycin for injection (Cubicin®) are covered.

Update on Drugs and Drug News: May-June 2016

Update on Betamethasone dipropionate 0.05% spray (Sernivo™), Dapsone 7.5% gel (Aczone®), Cobimetinib + vemurafenib (Cotellic™ + Zelboraf®), Botulinum toxin type A for injection (Bocouture®), Calcipotriol + betamethasone dipropionate foam (Enstilar®), (Talz®), (Inflectra™), (Pruridexin™), and (Dermadexin™)

Update on Drugs and Drug News: July-August 2013

Update on Dabrafenib mesilate capsule (Tafinlar®), Trametinib dimethyl sulfoxide tablet (Mekinist™), and Vismodegib capsule (Erivedge®)

Update on Drugs and Drug News: June, 2000

Update on: Paclitaxel Paxene Testosterone Gel AndroGel 1% “Intelligent” Dressing Acemannan Hydrogel Cyclophosphamide 25mg and 50mg tablets Ketoconazole 2% Cream Halofuginone OTC Vaginal Preparations Clotrimazole 2% Three Day Vaginal Cream Cyclosporine Gengraf Apligraf Graftskin

Update on Drugs and Drug News: September 2009

Update on Collagen-based dermal filler Evolence®, Injectable Poly-L-lactic acid Sculptra Aesthetic®, Ibritumomab tiuxetan Zevalin®, and news from US FDA on TNF blockers.

Update on Drugs and Drug News: February 2002

Updates on: Desloratidine Syrup & Disintegrating Tablets Moxifloxacin HCl IV Avelox®Photodynamic Therapy Metvix® PDT Etanercept Enbrel® Hydroquinone, Tretinoin & Flucinolone Cream Tri-Luma®

Update on Drugs & Devices: November-December 2023

Update on Bimekizumab-bkzx for SC injection (Bimzelx®), Clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%fixed-dose topical gel (Cabtreo™), Roflumilast cream 0.3% (Zoryve®), Nivolumab for IV use (Opdivo®), Secukinumab for IV use (Cosentyx®)

Update on Drugs and Drug News: January, 1999

Update on: Lidocaine 2.5%, prilocaine 2.5% Emla® patch Cyclosporin SangCya®Metronidazole lotion 0.75% Metrolotion® Imiquimod Aldara® 2-octylcyanoacrylate Dermabond Topical Skin Adhesive®Alitretinoin gel 0.1% Panretin®Loratidine Claritin®Cetirizine Zyrtec®Penciclovir Denavir®Lyme disease vaccine LYMErix®

Update on Drugs and Drug News: March-April 2013

Update on Ingenol mebutate gel (0.015%, 0.05%) Picato™, Adapalene 0.1% + benzoyl peroxide 2.5% gel (Epiduo®), and Hydrogel for skin and wound care (Vashe® Skin and Wound Hydrogel)

Update on Drugs and Drug News – December 2006 – January 2007

Update on Polymethylmethacrylate/ Bovine Collagen ArteFill® Artes Medical, Polyphenon® E Ointment 15% MediGene AG/ Bradley Pharmaceuticals, and drug news on melanoma and new vaccines.

Update on Drugs and Drug News: November-December 2016

Update on drugs, approval dates, and comments. Brodalumab for SC injection (Lumicef®), Etanercept-szzs for SC injection (Amjevita™), Propranolol hydrochloride oral solution 3.75 mg/ml (Hemangiol®), Calcipotriol 50 mcg/g + betamethasone dipropionate 0.5 mg/g foam (Enstilar®) are covered.

POPULAR

Advertisement